Consequences of prior alloimmunization during granulocyte transfusion

Area of Science:

• Immunology
• Transfusion Medicine
• Hematology

Background:

• Leukocyte-containing blood products can induce anti-leukocyte antibodies.
• These antibodies are detectable via lymphocytotoxicity, granulocytotoxicity, and leukoagglutination assays.
• Preformed antibodies may impact granulocyte transfusion efficacy.

Purpose of the Study:

• To evaluate the effect of preformed anti-leukocyte antibodies on granulocyte transfusion therapy.
• To assess the impact on leukocyte counts, neutrophil migration, and platelet levels.

Main Methods:

• Recipient beagles were sensitized to donor foxhound antigens.
• Granulocytopenia was induced using cyclophosphamide.
• Granulocytes were collected via continuous flow centrifugation and transfused.
• Transfusions were compared between sensitized and nonsensitized recipients.

Main Results:

• Sensitized recipients showed significantly lower one-hour posttransfusion leukocyte increments (p < .04).
• Neutrophil migration into a chemoattractant chamber was markedly reduced in sensitized animals (p < .0001).
• Profound thrombocytopenia occurred in sensitized recipients post-transfusion, but not in nonsensitized controls.

Conclusions:

• Preformed anti-leukocyte antibodies significantly impair granulocyte transfusion effectiveness.
• These antibodies reduce neutrophil function and lead to transfusion-associated thrombocytopenia.
• The findings highlight the clinical importance of assessing anti-leukocyte antibodies before transfusion.